BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21952998)

  • 21. [The incidence of the antiphospholipid syndrome in the clinical and biological manifestations of systemic lupus erythematosus].
    Sánchez Rodríguez A; Martín Oterino JA; Fidalgo Fernández MA; Araoz Sánchez P; Alonso García P; Fernández Navarro P; Chimpén Ruiz V; Portugal Alvarez J
    Rev Clin Esp; 1997 Oct; 197(10):669-74. PubMed ID: 9424663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor activity in patients with systemic lupus erythematosus: association with disease activity.
    Segal J; Kickler T; Petri M
    J Rheumatol; 2000 Dec; 27(12):2827-32. PubMed ID: 11128671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.